Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 284-698-4 | CAS number: 84962-05-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://chesar.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
Key study performed according to OECD guideline 422 and in accordance with GLP. NOAEL (No Observed Adverse Effect Level) for males and females was established at 1000 mg/kg body weight/day. The NOEL (No Observed Effect Level) for reproduction /developmental toxicity was considered to be 1000 mg/kg/day.
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- yes
- Remarks:
- relative humidity exceeded the given range in the guideline (18.4 - 66.2 % instead of 30 - 70 %)
- Qualifier:
- according to guideline
- Guideline:
- other: EPA OPPTS 870.3650 (Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test)
- Deviations:
- yes
- Remarks:
- relative humidity exceeded the given range in the guideline (18.4 - 66.2 % instead of 30 - 70 %)
- GLP compliance:
- yes
- Limit test:
- no
- Justification for study design:
- Recognized by international guidelines as a recommended test system.
- Specific details on test material used for the study:
- Identification: FAT 93580/A
CAS Number: 84962-05-0
Active Ingredients: Octadecanoic acid, reaction products with diethylenetriamine and urea, acetates
Description: White-yellowish waxy solid; odour: acetic acid
Batch Number: 0022357000
Purity/Concentration as Supplied: More than 90% of octadecanoic acid, reaction products with diethylenetriamine and urea, acetates
Purity: 94.3 %
Correction for Purity: No
Stability of Test Item in Vehicle: At least 8 days if stored at room temperature
Expiry Date (Retest Date) as handled by Harlan Laboratories Ltd: 31-Dec-2018
Storage Conditions: Room temperature (20 ± 5 °C), in the dark
Safety Precautions: Routine hygienic procedures (gloves, goggles, face mask). - Species:
- rat
- Strain:
- other: RccHan : WIST(SPF)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories BV, Netherlands
- Age at study initiation: 11 weeks
- Weight at study initiation: 339-389 g (males); 223-273 g (females)
- Fasting period before study: no
- Housing: In groups of three to five animals in Makrolon type-4 cages with wire mesh tops up to the day of randomization and afterwards individually in Makrolon type-3 cages with wire mesh tops and sterilized standard softwood bedding with paper enrichment. During the pre-pairing period, cages with males were interspersed amongst those holding females to promote the development of regular estrus cycles.
- Diet (e.g. ad libitum): pelleted standard Harlan Teklad 2018C rodent maintenance diet, ad libitum
- Water (e.g. ad libitum): community tap-water, ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20.9-23.6
- Humidity (%): 18.4-66.2
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
FAT #: 93580/A was weighed, crushed using a mortar and a small amount of vehicle was added to disperse the test item. The suspension was transferred to a glass beaker and the remaining vehicle was added. Using a magnetic stirrer and/or an ultra turrax, a homogeneous suspension was prepared. Separate formulations were prepared for each concentration. Homogeneity of the test item in the vehicle was maintained during the daily administration period using a magnetic stirrer. Dose formulations were stored at room temperature (20 ± 5 °C) in glass beakers. Based upon the results of stability analyses, dose formulations were stable for at least 8 days.
VEHICLE
- Justification for use and choice of vehicle (if other than water): no data
- Concentration in vehicle: 0, 25, 75, 250 mg/mL
- Amount of vehicle (if gavage): 4 mL/kg bw
- Lot/batch no.: 492194511, 103197718 - Details on mating procedure:
- - M/F ratio per cage: 1/1
- Length of cohabitation: maximum 14 days
- Proof of pregnancy: copulation plug / sperm in vaginal smear referred to as day 0 of pregnancy
- After 14 days of unsuccessful pairing replacement of first male by another male with proven fertility.
- Further matings after two unsuccessful attempts: no
- After successful mating each pregnant female was caged: individually - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- On the first treatment day samples from the control group as well as three samples (top, middle and bottom) of about 2 g of each concentration were taken prior to dosing for analysis of concentration and homogeneity. To confirm the stability (8 days) samples of about 2 g of each concentration were taken from the middle of each aliquot used on day 7 of the treatment. During the last week of the treatment, samples were taken from the middle to confirm concentration.
The aliquots for analysis of dose formulations were frozen (-20 ± 5 °C) and delivered on dry ice to the analytical laboratory and stored there at -20 ± 5 °C until analysis. The samples were analyzed by HPLC - ELSD detector. The test item was used as the analytical standard. - Duration of treatment / exposure:
- approximately 53 days
- Frequency of treatment:
- once daily
- Details on study schedule:
- Acclimatization: 7 days (males and females)
First test item administration: day 1 of pre-mating (males and females)
Pre-pairing: 15 days (males and females)
Blood sampling: day 15 of pre-mating (males and females)
Pairing: 14 days maximum (males and females)
Gestation: approximately 21 days (females)
Treatment ends: on day before sacrifice (males), on day 3 post-partum (females)
Necropsy: After treatment for 6 weeks, when no longer needed for assessment of reproductive effets (males), dams and pups on day 4 post-partum - Dose / conc.:
- 0 mg/kg bw/day (actual dose received)
- Remarks:
- Control Group (Group 1)
- Dose / conc.:
- 100 mg/kg bw/day (actual dose received)
- Remarks:
- Test group (Group - 2)
- Dose / conc.:
- 300 mg/kg bw/day (actual dose received)
- Remarks:
- Test group (Group - 3)
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- Remarks:
- Test group (Group - 4)
- No. of animals per sex per dose:
- 12 males and 12 females
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: The dose levels were selected based on a previous dose range-finding toxicity study in Wistar rat, using dose levels of 0, 100, 300 and 1000 mg/kg/day, where no test item related effects were observed up to the dose level of 1000 mg/kg/day.
- Positive control:
- No
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: for viability and mortality: twice daily, for cage-side clinical observations: once daily, during acclimatization and up to day of necropsy. Additionally females were observed for signs of difficult or prolonged parturition, and behavioral abnormalities in nesting and nursing.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: In males, it was performed once prior to the first administration of the test item and weekly thereafter. In females, it was performed once prior to the first administration of the test item, weekly during the pre-pairing and pairing periods and on days 0, 6, 13 and 20 of the gestation period.
BODY WEIGHT: Yes
- Time schedule for examinations: once during acclimatization and daily from treatment start to day of necropsy.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/animal/day: Yes
OTHER:
FUNCTIONAL OBSERVATION BATTERY:
- Time schedule for examinations: At one time during the study (males shortly before the scheduled sacrifice and females on day 3 post-partum) relevant parameters were performed with five P generation males and five P generation females from each group.
CLINICAL LABORATORY INVESTIGATIONS:
- Time schedule for examinations: Blood samples were obtained on day 15 of the pre-pairing period from 5 males and 5 females from each group. - Oestrous cyclicity (parental animals):
- no data
- Sperm parameters (parental animals):
- spermatogenesis
- Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: no
PARAMETERS EXAMINED
The following parameters were examined in F1 offspring: external examinations, sex ratios, body weights, stillbirths, presence of gross anomalies
GROSS EXAMINATION OF DEAD PUPS:
no data - Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals after treatment for 6 weeks, when no longer needed for assessment of reproductive effects
- Maternal animals: All surviving animals on day 4 post-partum
GROSS NECROPSY
- no details
HISTOPATHOLOGY / ORGAN WEIGHTS
The tissues indicated in Table 1 (Organ weights and preservation) were prepared for microscopic examination and weighed, respectively. - Postmortem examinations (offspring):
- GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations
HISTOPATHOLOGY / ORGAN WEIGTHS
- no details - Statistics:
- The following statistical methods were used to analyse food consumption, body weights, functional observational battery, locomotor activity, clinical laboratory investigations and reproduction data:
• Means and standard deviations of various data were calculated and included in the report.
• The Dunnett-test (many to one t-test) based on a pooled variance estimate was applied if the variables could be assumed to follow a normal distribution for the comparison of the treated groups and the control groups for each sex.
• The Steel-test (many-one rank test) was applied instead of the Dunnett-test when the data could not be assumed to follow a normal distribution.
• Fisher's exact-test was applied if the variables could be dichotomized without loss of information. - Reproductive indices:
- Corpora lutea, duration of gestation, implantation rate and post-implantation loss, litter size at first litter check, postnatal loss days 0-4 post-partum.
- Offspring viability indices:
- The viability index was 97.5, 99.3, 98.7 and 100 % in groups 1, 2, 3 and 4, respectively.
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- In group 3, female no. 78 was found with prolapsed vagina, ruffled fur and pale eyes on day 2 post partum, therefore the dam and its litter was killed for ethical reasons. This was considered to be incidental and not related to the treatment with the test item.
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- mortality observed, non-treatment-related
- Description (incidence):
- In group 3, one female (no. 78) was killed for ethical reason two days before scheduled necropsy due to prolapsed vagina and cervix.
All the other animals survived until the scheduled necropsy. - Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- MALES:
Pre-Pairing, Pairing and After Pairing Periods : At 1000 mg/kg body weight/day, mean body weights were slightly reduced from about day 10 of pre-pairing period throughout pairing and after pairing periods but without attaining statistical significance. Mean body weight gain was also reduced when compared to controls with statistically significance on days 12 and 13 of the pre-pairing period. Thereafter the body weight gain was comparable with controls in the pairing and after pairing periods.
No effects on body weights or body weight gains were observed at 300 and 100 mg/kg body weight/day.
FEMALES:
Pre-Pairing, Pairing, Gestation and Lactation Periods : No effects on body weights and body weight gains were observed during pre-pairing, gestation and early lactation periods for females. - Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Males
In group 4, the absolute values for white blood cell count, neutrophils and lymphocytes for males were statistically significantly lower when compared to the control but the values were within the range of the historical control data.
In groups 2 and 3 no altered parameters were observed.
Females
The assessment of the hematology data did not reveal any test item-related effects in females in any dose group.
In groups 4 and 3, statistically significantly lower hemoglobin level was noted (9.5 mmol/l each) but the values were within the historical control data (8.0 - 10.3 mmol/l). Therefore, it was not considered to be related to the treatment.
The significantly higher hematocrit value and monocytes count noted in group 2 were considered to be incidental. - Clinical biochemistry findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Males
In group 4, the levels of total cholesterol and total protein were statistically significantly decreased but the values were within the reference data.
The globulin level was also statistically significantly decreased, and the value was slightly below the historical data (20.84 g/l compared to 21.34 g/l in the reference data). These were not considered to be related to the treatment with the test item.
In group 3, the chloride concentration was statistically significantly higher than control, but it was not considered to be related to the treatment.
In group 2 statistically significantly decreased total protein and albumin level was noted. Due to the lack of dose dependency this was considered not to be related to the treatment with the test item.
Females
In group 4, the levels of alanine aminotransferase and potassium were statistically significantly increased but were within the historical background data.
In group 3, the total bilirubin was statistically significantly decreased due to three animals (nos. 73, 74, 75) with zero value. Due to the lack of dose dependency this was considered of no toxicological importance. No changes were noted in group 2. - Urinalysis findings:
- not examined
- Behaviour (functional findings):
- effects observed, treatment-related
- Description (incidence and severity):
- None of the parameters under investigation during the functional observational battery gave an indication of a test item-related effect.
Mean values of grip strength for hind paws of lactating females was dose dependently lower in all test item-treated groups when compared to current controls. - Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- effects observed, non-treatment-related
- Description (incidence and severity):
- In particular, qualitative examination of the stages of spermatogenesis in the testis did not reveal any treatment-related abnormalities in the integrity of the various cell types present within the different stages of the sperm cycle. No treatment-related microscopic abnormalities were observed in the evaluation of the ovarian follicles and corpora lutea of the ovaries or the evaluation of the uterus.
All other findings were typical of this strain and age of rat and were considered to be incidental. - Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
- Reproductive function: oestrous cycle:
- not examined
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- Mating performance and fertility did not give any indication to a test item-related effect in any dose group.
All females in groups 1, 2 and 3 mated within the first pairing period. In group 4, one female (no. 87) was mated during the second pairing period.
In group 2, for one female (no. 63) the mating was not detected when mated with male 16 and therefore was allocated to mate with male 15, where no mating happened because it was noted that she was already pregnant. This animal delivered viable pups but data of the dam and its litter were excluded from the summary tables of this report due to missing data of body weights and
food consumption in the gestation period.
Two females each in the control (nos. 53, 59) and group 2 (nos. 71, 72) and one female in group 4 (no. 85) were not pregnant.
The median and mean precoital times were unaffected by treatment with the test item. Mean precoital times were 3.8, 2.8, 2.6 and 3.6 days in groups 1, 2, 3 and 4, respectively. The median precoital time was 3, 3, 2 and 3 days in order of ascending dose level. For the female in group 4 that mated during the second pairing period.
The fertility index and conception rates were 83.3%, 83.3%, 100% and 91.7% in groups 1, 2, 3 and 4, respectively.
In group 4, female no. 93 delivered five pups but they were found dead at first litter check (for 3 out of 5 the sex was undetermined due to cannibalism). Due to this the gestation index was 90.9% in group 4 and 100% in all other dose groups. This finding was considered to be incidental. - Dose descriptor:
- NOAEL
- Remarks:
- general
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: the highest administered dose
- Dose descriptor:
- NOEL
- Remarks:
- for reproduction
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: the highest administered dose
- Clinical signs:
- effects observed, non-treatment-related
- Description (incidence and severity):
- No abnormal findings were noted at first litter check or during the first 4 days post partum.
In group 3, the pups of dam no. 78 with prolapsed vagina and one pup in group 2 (litter 67) were cold to touch and a wound was found of a group 4 pup (litter 94) on the posterior dorsum on day 1 post partum. These findings were considered not be related to the treatment with the test item - Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- Mean pup weights on day 1 and day 4 post partum were unaffected by treatment with the test item. On day 1 post partum mean pup weights were 6.3, 6.0, 6.1 and 6.3 g and on day 4 post partum were 9.6, 8.6, 9.2 and 9.7 g in order of ascending dose level.
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not examined
- Sexual maturation:
- not examined
- Anogenital distance (AGD):
- not examined
- Nipple retention in male pups:
- not examined
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- No test item-related findings were noted at macroscopic examination of F1 pups.
Discoloration of the lung for one male group 1 and 3 pup each and one group 2 female pup was observed and one control female pup was reduced in size. Additionally, sex was undetermined for three pups in group 4. - Histopathological findings:
- not specified
- Behaviour (functional findings):
- not examined
- Developmental immunotoxicity:
- not examined
- Key result
- Dose descriptor:
- NOEL
- Remarks:
- developmental toxicity
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: the highest administered dose
- Reproductive effects observed:
- not specified
- Conclusions:
- The NOEL for reproduction/developmental toxicity was concluded to be 1000 mg/kg bw/day.
- Executive summary:
The purpose of this study was to generate preliminary information concerning the effects of FAT #: 93580/A on the possible health hazards likely to arise from repeated exposure over a relatively limited period of time. In addition it provides information on possible effects on male and female reproductive performance such as gonadal function, mating behaviour, conception, development of the conceptus and parturition. The study was performed according to OECD TG 422 and EPA OPPTS 870.3650.
FAT 93580/A was administered to male rats for 6 weeks and to female rats for 14 days prior to pairing, through the pairing and gestation periods until the F1 generation reached day 4 post-partum.
The following dose levels were applied:
group 1 (control): 0 mg/kg bw/day,
group 2: 100 mg/kg bw/day,
group 3: 300 mg/kg bw/day,
group 4: 1000 mg/kg bw/day.
A standard dose volume of 4 mL/kg body weight with a daily adjustment to the actual body weight was used. Control animals were dosed with the vehicle alone (corn oil).
Observation:
In group 3, one female was killed for ethical reason two days before scheduled necropsy due to prolapsed vagina and cervix. All the other parental animals survived until the scheduled necropsy. No clinical signs related to the treatment with the test item were observed in males or females of P generation during the study. None of the parameters under investigation during the functional observational battery gave an indication of a test item-related effect for P generation. There was no indication of a test item-related effect observed in males and females of P generation in any treated group. There was no test item-related effect observed on food consumption of males and females of P generation in any dose group.
At 1000 mg/kg bw/day, mean body weights and mean body gains of males were slightly reduced in the pre-pairing period but it was a transient slight effect as the body weight gain was comparable with controls in the pairing and after pairing periods. No effects on body weights or body weight gains of males were observed at 300 and 100 mg/kg bw/day. No effects on body weights and body weight gains were observed during pre-pairing, gestation and early lactation periods for females in any dose group. The assessment of the haematology data did not reveal any test item-related effects in females and in males of P generation at any dose level. Clinical biochemistry investigation did not reveal any test item-related effect. There were no effects observed on reproduction and breeding data which could be related to the treatment with the test item. There were no effects on organ weights of males and females of P generation observed in any dose group. No test item-related macroscopic or microscopic findings were noted in P generation. The mean number of pups at first litter check and its sex ratio was not affected by the treatment with the test item. No abnormal pup was noted at any dose level. Mean pup weights on day 1 and day 4 post-partum were unaffected by treatment with the test item. No test item-related findings were noted at macroscopic examination of F1 pups.
Based on the findings of the study, a general NOAEL (No-Observed-Adverse-Effect-Level) was considered to be 1000 mg/kg bw/day. The reproductive/developmental NOEL (No Observed Effect Level) was considered to be 1000 mg/kg bw/day.
Reference
Mean number of corpora lutea per dam (determined at necropsy) was comparable with controls (15.0, 16.3, 15.7 and 15.3 in order of ascending dose level) and gave no indication of a test itemrelated effect.
Duration of Gestation:
The mean duration of gestation was unaffected by exposure to the test item. Mean duration of gestation was 21.7, 21.4, 21.7 and 21.8 days, in order of ascending dose level.
Implantation Rate and Post-Implantation Loss :
The implantation rate and post-implantation loss did not reveal any test item-related effects. The mean numbers of implantations per litter were 14.1, 15.4, 15.2 and 12.0 in order of ascending dose levels. The mean incidence of post-implantation loss as a percentage of total implantations was 16.3, 7.8, 8.3 and 15.9%, in order of ascending dose levels. The slightly lower mean number of implantations in the high dose group was considered to be not related to the treatment with the test item due to the lack of statistical significance and that they were in the historical background range (11.0 - 13.8). The post-implantation loss % of implantations was slightly exceeded the historical background range (3.7 - 14.4%) but it was lower than current control, therefore it was considered to be unrelated to treatment.
Litter Size at First Litter Check:
The litter size at first litter check and the birth index were not affected by the treatment with the test item. In groups 1, 2, 3 and 4 birth index was 83.7, 92.2, 91.1 and 84.1 % and mean litter size at first litter check was 11.8, 14.2, 13.8 and 10.1, respectively. In group 4, the mean litter size was slightly lower than current control but was within the historical control range (9.5 - 13.2).
Postnatal Loss Days 0 - 4 Post Partum:
There was no effect on post-natal loss between days 0 and 4 post partum. In group 4, female no. 93 delivered five pups but they were found dead at first litter check (for 3 out of 5 pups the sex was undetermined due to cannibalism). This was considered to be In group 3, one litter (no. 78) was killed for ethical reason since the mother had prolapsed vagina and showed severe clinical symptoms on day 2 post partum. Mean postnatal loss was 0.3, 0.1, 0.2 and 0.0 and the viability index was 97.5, 99.3, 98.7 and 100 % in groups 1, 2, 3 and 4, respectively.
CLINICAL SIGNS (OFFSPRING): No data
BODY WEIGHT (OFFSPRING): No effects
SEXUAL MATURATION (OFFSPRING): Not examined
ORGAN WEIGHTS (OFFSPRING): No data
GROSS PATHOLOGY (OFFSPRING): No effects
HISTOPATHOLOGY (OFFSPRING): No data
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- The key study with reliability rating 1 was performed according to OECD guideline 422 and in accordance with GLP.
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Short description of key information:
There were no effects observed on
reproduction and breeding data which could be related to the treatment
with the test item.
Justification for selection of Effect on fertility via oral route:
The study was conducted according to OECD guideline 422 and in
accordance with GLP
Effects on developmental toxicity
Description of key information
No abnormal findings were noted at first litter check or during the first 4 days post-partum.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- Key study with reliability rating 1 performed according to OECD guideline 422 and in accordance with GLP.
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Justification for selection of Effect on
developmental toxicity: via oral route:
The study was conducted according
to OECD guideline 422 and in accordance with GLP
Toxicity to reproduction: other studies
Additional information
Key study performed according to OECD guideline 422 and in accordance with GLP. NOAEL (No Observed Adverse Effect Level) for males and females was established at 1000 mg/kg body weight/day. The NOEL (No Observed Effect Level) for reproduction /developmental toxicity was considered to be 1000 mg/kg/day.
Justification for classification or non-classification
According to OECD TG 422 NOAEL (No Observed Adverse Effect Level) for males and females was established at 1000 mg/kg body weight/day. The NOEL (No Observed Effect Level) for reproduction /developmental toxicity was considered to be 1000 mg/kg/day. Hence the test substance FAT 93580/A can be regarded as not classified for reproduction /developmental toxicity.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)